Page last updated: 2024-10-26

edrophonium and Brugada ECG Pattern

edrophonium has been researched along with Brugada ECG Pattern in 1 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhar-Amato, J1
Finlay, M1
Santos, D1
Orini, M1
Chaubey, S1
Vyas, V1
Taggart, P1
Grace, AA1
Huang, CL1
Ben Simon, R1
Tinker, A1
Lambiase, PD1

Other Studies

1 other study available for edrophonium and Brugada ECG Pattern

ArticleYear
Pharmacological Modulation of Right Ventricular Endocardial-Epicardial Gradients in Brugada Syndrome.
    Circulation. Arrhythmia and electrophysiology, 2018, Volume: 11, Issue:9

    Topics: Action Potentials; Adult; Aged; Brugada Syndrome; Cardiac Catheterization; Case-Control Studies; Cho

2018